Omega Healthcare Investors, Inc. (OHI) Shares Sold by Nationwide Fund Advisors

Nationwide Fund Advisors reduced its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 20.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 334,354 shares of the real estate investment trust’s stock after selling 84,983 shares during the period. Nationwide Fund Advisors owned approximately 0.17% of Omega Healthcare Investors worth $10,669,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Bronfman E.L. Rothschild L.P. increased its stake in Omega Healthcare Investors by 167.7% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 3,432 shares of the real estate investment trust’s stock worth $113,000 after purchasing an additional 2,150 shares during the period. Ffcm LLC increased its stake in Omega Healthcare Investors by 197.6% during the second quarter. Ffcm LLC now owns 3,402 shares of the real estate investment trust’s stock worth $115,000 after purchasing an additional 2,259 shares during the period. Chicago Partners Investment Group LLC increased its stake in Omega Healthcare Investors by 656.6% during the second quarter. Chicago Partners Investment Group LLC now owns 6,015 shares of the real estate investment trust’s stock worth $193,000 after purchasing an additional 5,220 shares during the period. ARP Americas LLC purchased a new stake in Omega Healthcare Investors during the second quarter worth about $218,000. Finally, Cetera Investment Advisers purchased a new stake in Omega Healthcare Investors during the second quarter worth about $235,000. Hedge funds and other institutional investors own 68.14% of the company’s stock.

Omega Healthcare Investors, Inc. (OHI) traded down $0.03 during mid-day trading on Friday, hitting $27.88. 2,900,000 shares of the company were exchanged, compared to its average volume of 2,179,110. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.40 and a quick ratio of 3.40. Omega Healthcare Investors, Inc. has a 12-month low of $26.43 and a 12-month high of $35.14. The stock has a market capitalization of $5,530.21, a price-to-earnings ratio of 8.21, a price-to-earnings-growth ratio of 2.90 and a beta of 0.49.

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Tuesday, October 31st were paid a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a dividend yield of 9.33%. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.64. The ex-dividend date was Monday, October 30th. Omega Healthcare Investors’s dividend payout ratio is presently 317.08%.

A number of analysts have issued reports on OHI shares. ValuEngine lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, September 6th. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Thursday, September 28th. Jefferies Group reiterated a “hold” rating and set a $30.00 price target on shares of Omega Healthcare Investors in a research note on Tuesday, October 3rd. Vetr lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price target on the stock. in a research note on Thursday, October 19th. Finally, Capital One Financial started coverage on shares of Omega Healthcare Investors in a research note on Monday, October 23rd. They set an “equal weight” rating and a $34.00 target price on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $31.83.

In other Omega Healthcare Investors news, Director Bernard J. Korman purchased 100,000 shares of the stock in a transaction that occurred on Tuesday, October 31st. The stock was purchased at an average cost of $28.24 per share, with a total value of $2,824,000.00. Following the completion of the acquisition, the director now directly owns 903,895 shares of the company’s stock, valued at approximately $25,525,994.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Craig R. Callen purchased 10,000 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was acquired at an average cost of $27.38 per share, with a total value of $273,800.00. The disclosure for this purchase can be found here. 1.54% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY NOTICE: “Omega Healthcare Investors, Inc. (OHI) Shares Sold by Nationwide Fund Advisors” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://ledgergazette.com/2017/12/15/nationwide-fund-advisors-sells-84983-shares-of-omega-healthcare-investors-inc-ohi.html.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply